Textoris, Julien http://orcid.org/0000-0002-3821-9337
Gordon, Anthony C.
Article History
Received: 15 May 2018
Accepted: 16 May 2018
First Online: 14 June 2018
Compliance with ethical standards
:
: Julien Textoris is a part-time employee of an in vitro diagnostic company, bioMérieux, and part-time employee of Hospices Civils de Lyon. Both institutions hold patents related to sepsis biomarkers and JT is inventor on some of them. The views presented in this editorial are JT’s personal opinion and do not necessarily represent the viewpoint, strategy or opinions of bioMérieux. Anthony Gordon is supported by an NIHR Research Professorship (RP-2015-06-018) and the NIHR Imperial Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the department of health. He also reports that he has received speaker fees from Orion Corporation Orion Pharma and Amomed Pharma. He has consulted for Ferring Pharmaceuticals, Tenax Therapeutics, Baxter Healthcare, Bristol-Myers Squibb and GSK, and received grant support from Orion Corporation Orion Pharma, Tenax Therapeutics and HCA International with funds paid to his institution.